Parenteral Nutrition Support for Patients With Pancreatic Cancer

Phase 2

Completed

• Conditions: Cancer Cachexia; Pancreatic Cancer

• Registration Number: NCT00919659
• Lead Sponsor: CONKO-Studiengruppe

Brief Summary

The purpose of this study is to determine whether the additional nutrition support is improving the nutritional status of patients suffering cancer caxechia or not.

Detailed Description

To examine the impact of additional parenteral nutrition (APN) we prospective evaluated 32 pts suffering APC and progressive cachexia. This assay is based on a bioelectrical impedance analysis (BIA) as a proven tool for nutritional investigation in patients with chronic disease. Phase angle, determined by BIA, has been found to be a prognostic indicator in several chronic and malignant conditions, such as HIV, liver cirrhosis, chronic obstructive pulmonary disease lung cancer and pancreatic cancer.

Study Timeline

• Study Start: 2002-01
• Primary Completion: 2004-01
• Study Completion: 2004-05
• Status Verified: 2009-06
• Study First Submitted: 2009-06-09
• Study First Submitted QC: 2009-06-11
• Last Update Submitted: 2009-06-11
• Study First Posted: 2009-06-12
• Last Update Posted: 2009-06-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

• histological proved pancreatic cancer
• progressive cancer cachexia
• refractive to enteral supplementation
• informed consent

Exclusion Criteria

• prefinal status
• septic disease

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
nutritional status presented by phase angle	12 weeks

Secondary Outcome Measures

Name	Time	Method
quantity of port infections, quantity of oedema, quantity of diarrhea	12 weeks

Trial Locations

Locations (1)

Universitätsmedizin Berlin - Charité; 🇩🇪 Berlin, Germany